Ipsen SA

Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.

Filings

36 filings

All Share buyback75 Inside information54 Voting rights and capital36 Threshold crossing11 Earnings release10 Universal registration document6 AGM documents4 Half-year financial report4

22/07/2026
Ipsen - Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026
Voting rights and capitalFR
09/07/2026
Ipsen - June 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
08/06/2026
Ipsen - May 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
18/05/2026
Ipsen - April 2026- Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
13/03/2026
Ipsen - February 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
09/02/2026
Ipsen - January 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
07/01/2026
Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
08/12/2025
Ipsen - November 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
07/11/2025
Ipsen - October 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
07/10/2025
Ipsen - September 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
11/09/2025
Ipsen - August 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
27/08/2025
Ipsen - July 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
10/07/2025
Ipsen - June 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
12/06/2025
Ipsen - May 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
12/05/2025
Ipsen - April 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
14/04/2025
Ipsen - March 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
06/03/2025
Ipsen - February 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR
06/02/2025
Ipsen - January 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Voting rights and capitalFR

About

ISIN: FR0010259150
Ticker: IPN
LEI: 549300M6SGDPB4Z94P11
Sector: Health care
Founded: 1929
Employees: 5,300
Country of registration: FR
Last filing: 03/08/2026, 18:00

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive